Vanda Pharmaceuticals (VNDA) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -52.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.37% |
| Dec 31, 2025 | -15.90% |
| Sep 30, 2025 | 43.92% |
| Jun 30, 2025 | -1.53% |
| Mar 31, 2025 | 59.27% |
| Dec 31, 2024 | 29.14% |
| Sep 30, 2024 | 39.71% |
| Jun 30, 2024 | 23.57% |
| Mar 31, 2024 | -537.10% |
| Dec 31, 2023 | -37.93% |
| Sep 30, 2023 | 39.90% |
| Jun 30, 2023 | -315.77% |
| Mar 31, 2023 | 109.74% |
| Dec 31, 2022 | 141.63% |
| Sep 30, 2022 | -16.22% |
| Jun 30, 2022 | -7.48% |
| Mar 31, 2022 | 31.96% |
| Dec 31, 2021 | -18.05% |
| Sep 30, 2021 | -23.04% |
| Jun 30, 2021 | 30.37% |
| Mar 31, 2021 | -83.67% |
| Dec 31, 2020 | -62.19% |
| Sep 30, 2020 | -121.41% |
| Jun 30, 2020 | 35.15% |
| Mar 31, 2020 | 47.09% |
| Dec 31, 2019 | -40.37% |
| Sep 30, 2019 | -98.82% |
| Jun 30, 2019 | 4.03% |
| Mar 31, 2019 | -71.49% |
| Dec 31, 2018 | -77.37% |
| Sep 30, 2018 | -217.21% |
| Jun 30, 2018 | -235.37% |
| Mar 31, 2018 | 35.47% |
| Dec 31, 2017 | 31.20% |
| Sep 30, 2017 | -1.85% |
| Jun 30, 2017 | -36.84% |
| Mar 31, 2017 | -258.65% |
| Dec 31, 2016 | 28.54% |
| Sep 30, 2016 | 598.15% |
| Jun 30, 2016 | -151.90% |
| Mar 31, 2016 | -30.79% |
| Dec 31, 2015 | 62.81% |
| Sep 30, 2015 | -26.28% |
| Jun 30, 2015 | 57.41% |
| Mar 31, 2015 | -46.79% |
| Dec 31, 2014 | -39.49% |
| Sep 30, 2014 | -30.61% |
| Jun 30, 2014 | 43.82% |
| Mar 31, 2014 | -69.13% |
| Dec 31, 2013 | -5.37% |
| Sep 30, 2013 | 94.32% |